Serum liver-type fatty acid-binding protein predicts recovery of graft function after kidney transplantation from donors after cardiac death

Clinical Transplantation

Volumn 28, Issue 6, 2014, Pages 749-754

  Kawai, Akihiro ^a   Kusaka, Mamoru ^a   Kitagawa, Fumihiko ^a   Ishii, Junichi ^a   Fukami, Naohiko ^a   Maruyama, Takahiro ^a   Sasaki, Hitomi ^a   Shiroki, Ryoichi ^a   Kurahashi, Hiroki ^a   Hoshinaga, Kiyotaka ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Delayed graft function; Donation after cardiac death; Ischemia reperfusion injury; Kidney transplantation; Liver type fatty acid binding protein

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; FATTY ACID BINDING PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; BIOLOGICAL MARKER; FABP1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN DEATH; CONVALESCENCE; DELAYED GRAFT FUNCTION; FEMALE; HEART DEATH; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; CHILD; COMPARATIVE STUDY; DEATH; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; JAPAN; KIDNEY FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN DEATH; CHILD; DEATH; DELAYED GRAFT FUNCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; JAPAN; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TISSUE DONORS; YOUNG ADULT;

EID: 84901843589     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12375     Document Type: Article

References (27)

1. Wijnen RM, Booster MH, Stubenitsky BM et al. Outcome of transplantation of non-heart-beating donor kidneys. Lancet 1067: 1995: 345.
2. Gagandeep S, Matsuoka L, Mateo R et al. Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant 2006: 6: 1682.
3. Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998: 54: 972.
4. Prommool S, Jhangri GS, Cockfield SM et al. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000: 11: 565.
5. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004: 65: 713.
6. Sayegh MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1967: 1999: 65.
7. Brier ME, Ray PC, Klein JB. Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 2003: 18: 2655.
8. Shoskes DA, Cecka M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998: 66: 1697.
9. Kusaka M, Kuroynagi Y, Kowa H et al. Genome-wide expression profiles of rat model renal isografts from brain dead donors. Transplantation 2007: 83: 62.
10. Kusaka M, Kuroyanagi Y, Mori T et al. Global expression profiles in one hour biopsy specimens of human kidney transplantation from donors after cardiac death. Cell Transplant 2009: 18: 647.
11. Kusaka M, Kuroyanagi Y, Mori T et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 2008: 17: 129.
12. Kusaka M, Iwamatsu F, Kuroyanagi Y et al. Serum neutrophil gelatinase associated lipocalin during the early postoperative period predicts the recovery of graft function after kidney transplantation from donors after cardiac death. J Urol 2012: 187: 2261.
13. Kusaka M, Kuroyanagi Y, Ichino M et al. Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 2010: 19: 723.
14. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006: 47: 39.
15. Yamamoto T, Noiri E, Ono Y et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007: 18: 2894.
16. Kootstra G, Kievit JK, Heineman E. The non heart-beating donor. Br Med Bull 1997: 53: 844.
17. Koning OH, Ploeg RJ, van Bockel JH et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997: 63: 1620.
18. Kamijo A, Kimura K, Sugaya T et al. Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease. J Lab Clin Med 2004: 143: 23.
19. Kamijo A, Sugaya T, Hikawa A et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006: 284: 175.
20. Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008: 73: 465.
21. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008: 241: 89.
22. Maatman RG, van de Westerlo EM, van Kuppevelt TH et al. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992: 288: 285.
23. Oyama Y, Takeda T, Hama H et al. Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 2005: 85: 522.
24. Pelsers MM, Morovat A, Alexander GJ et al. Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem 2002: 48: 2055.
25. Wang G, Gong Y, Anderson J et al. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2005: 42: 871.
26. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004: 165: 1243.
27. Negishi K, Noiri E, Maeda R et al. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008: 73: 1374.